AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
Recruiting · NCT07617337 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer | ALK Positive Non-small Cell Lung Cancer | Recruiting | Phase 1 | 2026-09-18 | NCT07617337 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chugai Pharmaceutical | 25 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aichi Cancer Center Hospital | Nagoya | Japan | 30 |
| Kindai University Hospital | Sakai | Japan | 26 |
| National Cancer Center Hospital | Chuo-ku | Japan | 1 |
| National Cancer Center Hospital East | Kashiwa | Japan | 67 |
| Shizuoka Cancer Center | Nagaizumi-cho | Japan | 13 |
| The Cancer Institute Hospital of JFCR (Japanese Foundation for Cancer Research) | Koto-Ku | Japan | 1 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |